查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1448678

全球器官晶片市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测

Global Organs-on-chips Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 351 Pages | 商品交期: 最快1-2个工作天内

价格

全球器官晶片市场需求预计将从2023年的1.1726亿美元达到2032年的近15.4144亿美元，2024-2032年研究期间的CAGR为33.14%。

器官晶片是一种微流体装置，可以在微型规模上复製人体器官的结构和功能特征。这些晶片包含活细胞并模拟生理环境，使研究人员能够研究器官层面对药物和疾病的反应。该技术为传统动物测试提供了更准确、更合乎道德的替代方案，为药物开发和个人化医疗提供了人类生物学的宝贵见解。

市场动态

由于伦理问题以及对更多与人类相关的研究模型的需求，对传统动物测试方法替代方法的需求不断增加，推动了采用。此外，对个人化医疗和药物开发的关注放大了准确的体外测试平台的重要性。器官晶片技术提供了一个更生理相关的环境，有助于更好地理解器官层面的反应。此外，製药公司和器官晶片製造商之间的合作有助于市场成长，促进创新和研究。精准医疗的推动，加上微加工技术的进步，进一步加速了市场扩张。随着製药和生物技术产业优先考虑更安全、更有效率的药物开发流程，器官晶片市场可望持续成长，彻底改变临床前测试的模式。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球器官晶片市场的各个细分市场进行了包容性评估。器官晶片产业的成长和趋势为这项研究提供了整体方法。

市场区隔

晶片器官市场报告的这一部分提供了国家和区域层面细分市场的详细资料，从而帮助策略家确定相应产品或服务的目标人口统计数据以及即将到来的机会。

按类型

  • 产品（肝臟晶片、肺晶片、心臟晶片、肾臟晶片、其他产品）
  • 服务

按材质

  • 聚二甲基硅氧烷 (Pdms)
  • 聚合物
  • 玻璃

按型号类型

  • 单一器官模型
  • 多重器官模型

按应用

  • 药物发现
  • 毒性测试
  • 疾病建模
  • 个人化医疗
  • 其他

按最终用户

  • 製药和生物技术公司
  • 学术及研究机构
  • 其他

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲的器官晶片市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。器官晶片市场的主要参与者包括 Altis Biosystems、AlveoliX AG、Axosim、Bi/ond Solutions BV、Cherry Biotech、CN-Bio、Emulate, Inc.、Hesperos, Inc.、Insphero、MesoBioTech、Mimetas BV、 Nortis Inc.、 React4Life、TARA Biosystems（Valo Health）、TissUse GmbH。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法论
    • 市场研究过程
    • 市场研究方法论

第 2 章：执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章：器官晶片 - 产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业动态
  • 波特五力分析
  • 市场吸引力分析
    • 按类型分類的市场吸引力分析
    • 按材料分類的市场吸引力分析
    • 按模型类型分類的市场吸引力分析
    • 市场吸引力分析：依应用分类
    • 最终用户的市场吸引力分析
    • 市场吸引力分析：按地区

第 4 章：价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料厂商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章：全球晶片器官市场分析：按类型

  • 按类型概述
  • 历史和预测数据
  • 按类型分析
  • 产品（肝臟晶片、肺晶片、心臟晶片、肾臟晶片、其他产品）
  • 服务

第 6 章：全球器官晶片市场分析：依材料分类

  • 按材料概述
  • 历史和预测数据
  • 按材料分析
  • 聚二甲基硅氧烷 (Pdms)
  • 聚合物
  • 玻璃

第 7 章：全球晶片器官市场分析：依模型类型

  • 按型号类型概述
  • 历史和预测数据
  • 按模型类型分析
  • 单一器官模型
  • 多重器官模型

第 8 章：全球晶片器官市场分析：依应用分类

  • 概述：按应用
  • 历史和预测数据
  • 分析：按应用
  • 药物发现
  • 毒性测试
  • 疾病建模
  • 个人化医疗
  • 其他

第 9 章：全球晶片器官市场分析：依最终用户分类

  • 最终用户概述
  • 历史和预测数据
  • 最终用户分析
  • 製药和生物技术公司
  • 学术及研究机构
  • 其他

第 10 章：全球晶片器官市场分析：依地理位置

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概览、历史与预测资料销售分析
    • 北美按细分市场销售分析
    • 北美按国家销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概览、历史与预测资料销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概览、历史与预测资料销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区国家/地区销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概览、历史与预测资料销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概览、历史与预测资料销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第 11 章：器官晶片公司的竞争格局

  • 器官晶片市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 12 章：公司简介

  • 公司股份分析
  • 市场集中度
  • Altis Biosystems
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • AlveoliX AG
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Axosim
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Bi/ond Solutions BV
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Cherry Biotech
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • CN-Bio
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Emulate Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Hesperos Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Insphero
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • MesoBioTech
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Mimetas BV
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Nortis Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • React4Life
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • TARA Biosystems (Valo Health)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • TissUse GmbH.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展

注意 - 在公司概况中，财务详细资讯和近期发展视情况而定，或者如果是私人公司，则可能不包括在内

Product Code: VMR112113662

The global demand for Organs-on-chips Market is presumed to reach the market size of nearly USD 1541.44 Million by 2032 from USD 117.26 Million in 2023 with a CAGR of 33.14% under the study period 2024 - 2032.

Organs-on-chips are microfluidic devices that replicate the structural and functional traits of human organs on a miniature scale. These chips contain living cells and simulate the physiological environment, allowing researchers to study organ-level responses to drugs and diseases. This technology offers a more accurate and ethical alternative to traditional animal testing, providing valuable insights into human biology for drug development and personalized medicine.

MARKET DYNAMICS

The increasing demand for alternatives to traditional animal testing methods due to ethical concerns and the need for more human-relevant research models drives adoption. Additionally, the focus on personalized medicine and drug development amplifies the significance of accurate in vitro testing platforms. The organs-on-chips technology offers a more physiologically relevant environment, enabling a better understanding of organ-level responses. Moreover, collaborations between pharmaceutical companies and organs-on-chips manufacturers contribute to market growth, fostering innovation and research. The push for precision medicine, coupled with advancements in microfabrication techniques, further accelerates market expansion. As the pharmaceutical and biotechnology industries prioritize safer and more efficient drug development processes, the organs-on-chips market is poised for sustained growth, revolutionizing the landscape of preclinical testing.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of organs-on-chips. The growth and trends of organs-on-chips industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the organs-on-chips market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

  • Product (Liver-On-Chip, Lung-On-Chip, Heart-On-Chip, Kidney-On-Chip, Other Products)
  • Service

By Material

  • Polydimethylsiloxane (Pdms)
  • Polymer
  • Glass

By Model Type

  • Single-Organ Model
  • Multi-Organ Model

By Application

  • Drug Discovery
  • Toxicity Testing
  • Disease Modeling
  • Personalized Medicine
  • Other

By End-User

  • Pharmaceutical And Biotechnology Companies
  • Academic And Research Institutes
  • Other

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Organs-on-chips market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Organs-on-chips market include Altis Biosystems, AlveoliX AG, Axosim, Bi/ond Solutions B.V, Cherry Biotech, CN-Bio, Emulate, Inc., Hesperos, Inc., Insphero, MesoBioTech, Mimetas B.V., Nortis Inc., React4Life, TARA Biosystems (Valo Health), TissUse GmbH. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . ORGANS-ON-CHIPS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Type
    • 3.7.2 Market Attractiveness Analysis By Material
    • 3.7.3 Market Attractiveness Analysis By Model Type
    • 3.7.4 Market Attractiveness Analysis By Application
    • 3.7.5 Market Attractiveness Analysis By End-User
    • 3.7.6 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL ORGANS-ON-CHIPS MARKET ANALYSIS BY TYPE

  • 5.1 Overview by Type
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Type
  • 5.4 Product (Liver-On-Chip, Lung-On-Chip, Heart-On-Chip, Kidney-On-Chip, Other Products) Historic and Forecast Sales by Regions
  • 5.5 Service Historic and Forecast Sales by Regions

6 . GLOBAL ORGANS-ON-CHIPS MARKET ANALYSIS BY MATERIAL

  • 6.1 Overview by Material
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Material
  • 6.4 Polydimethylsiloxane (Pdms) Historic and Forecast Sales by Regions
  • 6.5 Polymer Historic and Forecast Sales by Regions
  • 6.6 Glass Historic and Forecast Sales by Regions

7 . GLOBAL ORGANS-ON-CHIPS MARKET ANALYSIS BY MODEL TYPE

  • 7.1 Overview by Model Type
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Model Type
  • 7.4 Single-Organ Model Historic and Forecast Sales by Regions
  • 7.5 Multi-Organ Model Historic and Forecast Sales by Regions

8 . GLOBAL ORGANS-ON-CHIPS MARKET ANALYSIS BY APPLICATION

  • 8.1 Overview by Application
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by Application
  • 8.4 Drug Discovery Historic and Forecast Sales by Regions
  • 8.5 Toxicity Testing Historic and Forecast Sales by Regions
  • 8.6 Disease Modeling Historic and Forecast Sales by Regions
  • 8.7 Personalized Medicine Historic and Forecast Sales by Regions
  • 8.8 Other Historic and Forecast Sales by Regions

9 . GLOBAL ORGANS-ON-CHIPS MARKET ANALYSIS BY END-USER

  • 9.1 Overview by End-User
  • 9.2 Historical and Forecast Data
  • 9.3 Analysis by End-User
  • 9.4 Pharmaceutical And Biotechnology Companies Historic and Forecast Sales by Regions
  • 9.5 Academic And Research Institutes Historic and Forecast Sales by Regions
  • 9.6 Other Historic and Forecast Sales by Regions

10 . GLOBAL ORGANS-ON-CHIPS MARKET ANALYSIS BY GEOGRAPHY

  • 10.1. Regional Outlook
  • 10.2. Introduction
  • 10.3. North America Sales Analysis
    • 10.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 10.3.2. North America By Segment Sales Analysis
    • 10.3.3. North America By Country Sales Analysis
    • 10.3.4. United State Sales Analysis
    • 10.3.5. Canada Sales Analysis
    • 10.3.6. Mexico Sales Analysis
  • 10.4. Europe Sales Analysis
    • 10.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 10.4.2. Europe by Segment Sales Analysis
    • 10.4.3. Europe by Country Sales Analysis
    • 10.4.4. United Kingdom Sales Analysis
    • 10.4.5. France Sales Analysis
    • 10.4.6. Germany Sales Analysis
    • 10.4.7. Italy Sales Analysis
    • 10.4.8. Russia Sales Analysis
    • 10.4.9. Rest Of Europe Sales Analysis
  • 10.5. Asia Pacific Sales Analysis
    • 10.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 10.5.2. Asia Pacific by Segment Sales Analysis
    • 10.5.3. Asia Pacific by Country Sales Analysis
    • 10.5.4. China Sales Analysis
    • 10.5.5. India Sales Analysis
    • 10.5.6. Japan Sales Analysis
    • 10.5.7. South Korea Sales Analysis
    • 10.5.8. Australia Sales Analysis
    • 10.5.9. South East Asia Sales Analysis
    • 10.5.10. Rest Of Asia Pacific Sales Analysis
  • 10.6. Latin America Sales Analysis
    • 10.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 10.6.2. Latin America by Segment Sales Analysis
    • 10.6.3. Latin America by Country Sales Analysis
    • 10.6.4. Brazil Sales Analysis
    • 10.6.5. Argentina Sales Analysis
    • 10.6.6. Peru Sales Analysis
    • 10.6.7. Chile Sales Analysis
    • 10.6.8. Rest of Latin America Sales Analysis
  • 10.7. Middle East & Africa Sales Analysis
    • 10.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 10.7.2. Middle East & Africa by Segment Sales Analysis
    • 10.7.3. Middle East & Africa by Country Sales Analysis
    • 10.7.4. Saudi Arabia Sales Analysis
    • 10.7.5. UAE Sales Analysis
    • 10.7.6. Israel Sales Analysis
    • 10.7.7. South Africa Sales Analysis
    • 10.7.8. Rest Of Middle East And Africa Sales Analysis

11 . COMPETITIVE LANDSCAPE OF THE ORGANS-ON-CHIPS COMPANIES

  • 11.1. Organs-On-Chips Market Competition
  • 11.2. Partnership/Collaboration/Agreement
  • 11.3. Merger And Acquisitions
  • 11.4. New Product Launch
  • 11.5. Other Developments

12 . COMPANY PROFILES OF ORGANS-ON-CHIPS INDUSTRY

  • 12.1. Company Share Analysis
  • 12.2. Market Concentration Rate
  • 12.3. Altis Biosystems
    • 12.3.1. Company Overview
    • 12.3.2. Company Revenue
    • 12.3.3. Products
    • 12.3.4. Recent Developments
  • 12.4. AlveoliX AG
    • 12.4.1. Company Overview
    • 12.4.2. Company Revenue
    • 12.4.3. Products
    • 12.4.4. Recent Developments
  • 12.5. Axosim
    • 12.5.1. Company Overview
    • 12.5.2. Company Revenue
    • 12.5.3. Products
    • 12.5.4. Recent Developments
  • 12.6. Bi/ond Solutions B.V
    • 12.6.1. Company Overview
    • 12.6.2. Company Revenue
    • 12.6.3. Products
    • 12.6.4. Recent Developments
  • 12.7. Cherry Biotech
    • 12.7.1. Company Overview
    • 12.7.2. Company Revenue
    • 12.7.3. Products
    • 12.7.4. Recent Developments
  • 12.8. CN-Bio
    • 12.8.1. Company Overview
    • 12.8.2. Company Revenue
    • 12.8.3. Products
    • 12.8.4. Recent Developments
  • 12.9. Emulate Inc.
    • 12.9.1. Company Overview
    • 12.9.2. Company Revenue
    • 12.9.3. Products
    • 12.9.4. Recent Developments
  • 12.10. Hesperos Inc.
    • 12.10.1. Company Overview
    • 12.10.2. Company Revenue
    • 12.10.3. Products
    • 12.10.4. Recent Developments
  • 12.11. Insphero
    • 12.11.1. Company Overview
    • 12.11.2. Company Revenue
    • 12.11.3. Products
    • 12.11.4. Recent Developments
  • 12.12. MesoBioTech
    • 12.12.1. Company Overview
    • 12.12.2. Company Revenue
    • 12.12.3. Products
    • 12.12.4. Recent Developments
  • 12.13. Mimetas B.V.
    • 12.13.1. Company Overview
    • 12.13.2. Company Revenue
    • 12.13.3. Products
    • 12.13.4. Recent Developments
  • 12.14. Nortis Inc.
    • 12.14.1. Company Overview
    • 12.14.2. Company Revenue
    • 12.14.3. Products
    • 12.14.4. Recent Developments
  • 12.15. React4Life
    • 12.15.1. Company Overview
    • 12.15.2. Company Revenue
    • 12.15.3. Products
    • 12.15.4. Recent Developments
  • 12.16. TARA Biosystems (Valo Health)
    • 12.16.1. Company Overview
    • 12.16.2. Company Revenue
    • 12.16.3. Products
    • 12.16.4. Recent Developments
  • 12.17. TissUse GmbH.
    • 12.17.1. Company Overview
    • 12.17.2. Company Revenue
    • 12.17.3. Products
    • 12.17.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis by Type (USD MN)
  • Product (Liver-On-Chip, Lung-On-Chip, Heart-On-Chip, Kidney-On-Chip, Other Products) Market Sales by Geography (USD MN)
  • Service Market Sales by Geography (USD MN)
  • Analysis Market by Material (USD MN)
  • Polydimethylsiloxane (Pdms) Market Sales by Geography (USD MN)
  • Polymer Market Sales by Geography (USD MN)
  • Glass Market Sales by Geography (USD MN)
  • Analysis by Model Type (USD MN)
  • Single-Organ Model Market Sales by Geography (USD MN)
  • Multi-Organ Model Market Sales by Geography (USD MN)
  • Analysis by Application (USD MN)
  • Drug Discovery Market Sales by Geography (USD MN)
  • Toxicity Testing Market Sales by Geography (USD MN)
  • Disease Modeling Market Sales by Geography (USD MN)
  • Personalized Medicine Market Sales by Geography (USD MN)
  • Other Market Sales by Geography (USD MN)
  • Analysis by End-User (USD MN)
  • Pharmaceutical And Biotechnology Companies Market Sales by Geography (USD MN)
  • Academic And Research Institutes Market Sales by Geography (USD MN)
  • Other Market Sales by Geography (USD MN)
  • Global Organs-On-Chips Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Organs-On-Chips Report
  • Market Research Process
  • Market Research Methodology
  • Global Organs-On-Chips Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Type
  • Market Attractiveness Analysis by Material
  • Market Attractiveness Analysis by Model Type
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by End-User
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Type (USD MN)
  • Product (Liver-On-Chip, Lung-On-Chip, Heart-On-Chip, Kidney-On-Chip, Other Products) Market Sales by Geography (USD MN)
  • Service Market Sales by Geography (USD MN)
  • Global Market Analysis by Material (USD MN)
  • Polydimethylsiloxane (Pdms) Market Sales by Geography (USD MN)
  • Polymer Market Sales by Geography (USD MN)
  • Glass Market Sales by Geography (USD MN)
  • Global Market Analysis by Model Type (USD MN)
  • Single-Organ Model Market Sales by Geography (USD MN)
  • Multi-Organ Model Market Sales by Geography (USD MN)
  • Global Market Analysis by Application (USD MN)
  • Drug Discovery Market Sales by Geography (USD MN)
  • Toxicity Testing Market Sales by Geography (USD MN)
  • Disease Modeling Market Sales by Geography (USD MN)
  • Personalized Medicine Market Sales by Geography (USD MN)
  • Other Market Sales by Geography (USD MN)
  • Global Market Analysis by End-User (USD MN)
  • Pharmaceutical And Biotechnology Companies Market Sales by Geography (USD MN)
  • Academic And Research Institutes Market Sales by Geography (USD MN)
  • Other Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.